If you are interested in showcasing your company’s services to senior clinical development executives from Chinese and US BioPharmas, please contact: firstname.lastname@example.org.
PPC was established in 1997 and is a subsidiary of Novotech Health Holdings ("Novotech"). Novotech is a full-service clinical CRO with labs, phase I facilities, and drug development consulting services. It has accumulated experience in over 3,700 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. Novotech Health Holdings is positioned to serve biopharmaceutical clients conducting clinical trials in Asia and globally. As of now, NHH had a total of over 2,500 FTEs working across 21 offices in 14 geographies around the globe.
Redbud Medicine, established by clinical experts from the multi-national pharmaceutical companies and FDA senior reviewer, and is rooted in both China and US, which are two most important new drug R&D markets, and is a global clinical research partner of innovative biotech and biopharma companies. Redbud could deliver a regulatory strategy to medical, clinical operations to data management and biostatistics expertise etc. Redbud has a rich KOL resources and strong site networks. Redbud already built up an integrated clinical operation team and data management system and provides the rapid one-stop solutions from regulatory affairs and clinical operation of global clinical study, and the implementation of medical strategy, ensuring to accelerate the entry of Chinese innovative drugs into the world.
The PPD clinical research business of Thermo Fisher Scientific is a leading global contract research organization, providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations. With more than 28,000 professionals worldwide, PPD has conducted clinical trials in more than 100 countries to help customers deliver life-changing therapies to improve health. We apply innovative technologies, therapeutic expertise and a firm commitment to quality to bend the cost and time curve of drug development and optimize value. For more information, visit thermofisher.com/ppd.
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. In 1982, Sanofi opened an office in China as one of the first multinational corporations to support China’s opening up and reform. We have 12 offices with diverse models, 3 production sites, 4 R&D sites and 1 digital innovation hub in China. Sanofi China has a diversified business that ranges from pharmaceuticals and human vaccines to consumer healthcare. As a multinational in China, Sanofi is committed to introducing innovative medicines and vaccines faster in China and transforming the practice of medicine to serve the broadest base of the Chinese people, and never stops questing to make life better for patients, partners, communities, and our own people.
For more information, please visit www.sanofi.cn or subscribe to the Sanofi China official WeChat account: SanofiChina (赛诺菲中国).
Shanghai Jsure Health
Shanghai Jsure Health Inc. is the leading digital patient solution provider in the pharmaceutical industry in China. Jsure is now the proud pioneer and champion in this market segment. Jsure Health strives for unrelenting innovation, building digital tools and platforms, such as “Xinmu”, “Light of Novel Drugs” and “Zhaoyaoshenqi”. Up till now, Jsure has engaged in 700+ new drug clinical trials, involving 50+ disease fields, cooperating with 1500+hospitals spreading in 200+ cities. In total, Jsure has served 51700+ patients. Connecting the latest beneficial treatment solutions to patients worldwide.For more information, please visit our website: www.jsure.com. T.: (86 21) 31229190 | E: email@example.com
Xincere Health Technology
Xincere Health Technology Co., Ltd., is the leading Decentralized Clinical Trial (DCT) platform solution supplier in China, which focuses on the development of a patient-centric intelligent platform for remote clinical trials. Incubated from Jsure Health after a four-year endeavor, Xincere has developed a business line featuring includes: ePData –Electric Clinical Outcome Assessment (eCOA) solution, ePDiary – Electric Diary, ePConsent – Electric Information Consent, ePVisit – Televisit solution, ePScale – Introduction and Copyright management service for domestic and international scales. Devoted to digital technology development as support for novel drug R&D advancement in China, we hope to help the patients and benefit the society.For more information please visit our website: www.xinceremed.com. T.: 021 - 3175 1502*8113 | E: firstname.lastname@example.org
Aurora (Yaocheng Healthcare Technology)
Aurora (Yaocheng Healthcare Technology) focuses on the life sciences clinical research management to provide a global leading SaaS platform for transforming clinical operations and clinical data management with the most comprehensive suite of clinical solutions. Enable technology-driven process improvements throughout the trial for data quality, operation efficiency, and cost controlling. Aurora’s experienced talents come from several global leading companies like Google, Verily, Splunk, Medidata, Veeva, & etc..
Caidya is a multi-therapeutic clinical research organization (CRO) serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance. Caidya leverages industry-leading and proprietary clinical technology to ensure trial transparency and data-driven decision-making. Formed in 2021 following the merger of leading CROs, dMed and Clinipace, Caidya has nearly 1,800 employees in 30+ countries throughout the world.
ICON is the world’s leading clinical research organization, powered by healthcare intelligence. From molecule to medicine, we advance clinical
research providing outsourced development and commercialization services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 39,300 employees in 138 locations in 53 countries as 2022.
For further information about ICON, visit: www.iconplc.com.
As an imaging CRO, Median Technologies has unmatched clinical, technological, and operational expertise in oncology trials. With our offices based in the US, Europe and China, we operate globally to deliver best-in-class end-to-end imaging services for your Phase I to III oncology trials. Our technology delivers high-quality image data for faster GO/NO GO decisions, with a high level of automation to reduce variability and increase accuracy and reproducibility.
Median excel in all areas of managing oncologic images in clinical trials. We are currently working with 2,400+ investigator sites throughout the world and with more than 50 biopharma sponsors. We have a unique knowledge of the various imaging criteria used in clinical trials covering all solid tumor cancer indications. We have successfully supported more than 10 new drug application approvals by China NMPA, US FDA, EMA and Japan PMDA.
MERIT is an innovative clinical endpoint expert specializing in the ophthalmology, respiratory, and oncology therapeutic areas. Together our work advances and accelerates the improvement of therapeutic options for patients worldwide. Our ophthalmology team are experts in managing and evaluating images, especially with ocular diseases affecting the retina. MERIT offers agile and attentive centralized spirometry expertise as a reliable respiratory services provider. We also provide end-to-end central oncology imaging services powered by our proprietary single system software, EXCELSIOR™.
Our decades of experience allow us to hit the ground running on your project. You can feel confident in our proven track record; MERIT has supported twelve of the top twenty global pharmaceutical companies. Our clients rely on us as a trusted R&D partner. If you’re looking for a clinical trial endpoint services provider that will value your partnership and make your study a priority, consider MERIT.
Thermo Fisher Scientific provides industry-leading pharma services solutions for drug development, clinical trial logistics and commercial manufacturing to customers through our Patheon brand.
With more than 65 locations around the world, we provide integrated, end-to-end capabilities across all phases of development, including API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics services and commercial manufacturing and packaging. We give pharma and biotech companies of all sizes instant access to a global network of facilities and technical experts across the Americas, Europe, Asia and Australia. Our global leadership is built on a reputation for scientific and technical excellence. We offer integrated drug development and clinical services tailored to fit your drug development journey through our Quick to Care program. As a leading pharma services provider, we deliver unrivaled quality, reliability and compliance. Together with our customers, we’re rapidly turning pharmaceutical possibilities into realities.
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,200 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.